Sustained off therapy response after peglyated interferon favours functional cure and no disease progression in chronic hepatitis B.

Soon Kyu LeeJung Hyun KwonSung Won LeeJeong Won JangHeechul NamKyoung Won BaikSun Hong YooSoon Woo NamPil-Soo SungSi Hyun BaeJong Young ChoiSeung Kew Yoon

Published in: Liver international : official journal of the International Association for the Study of the Liver (2020)

During long-term follow-up after PEG-IFN treatment, nearly half of patients achieved sustained response without the need of further NA and these patients displayed favourable outcomes, including HBsAg loss and no disease progression.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
hepatitis b virus
peritoneal dialysis
stem cells
immune response
metabolic syndrome
drug delivery
adipose tissue
patient reported outcomes
mesenchymal stem cells
insulin resistance
cell therapy
liver fibrosis